Results 191 to 200 of about 98,417 (285)

Use of Phosphorus-32 Microparticles for Downstaging Locally Advanced Pancreatic Cancer to Resection: A Case Report. [PDF]

Cureus
Pereira F, Juez I, Peiro V, Guardiola A, Del Riego C, Haro P.   +5 more
europepmc   +1 more source

‘BJUI Clinical Dilemma’: Recurrent high‐grade non‐muscle‐invasive bladder cancer in 2026

BJU International, Volume 138, Issue 1, Page 14-21, July 2026.
Vignesh T. Packiam, Peter C. Black, James W. F. Catto, Saum Ghodoussipour, Max Kates, Ashish M. Kamat, Yair Lotan, Michael A. O’Donnell, Jeremy Y. C. Teoh, George N. Thalmann, Stephen B. Williams   +10 more
wiley   +1 more source

Expert Consensus on the Clinical Application of Poly ADP Ribose Polymerase Inhibitors in Breast Cancer (2025 Edition)

Cancer Innovation, Volume 5, Issue 3, June 2026.
This consensus, based on the latest evidence‐based medical data, provides guidance on the standardized application and safety management of PARP inhibitors in breast cancer treatment, aiming to serve as a reference for clinical practice. ABSTRACT Breast cancer represents a major threat to women's health in China.
Fei Ma, Binghe Xu, China Anti‐Cancer Association Committee on Clinical Research of Anticancer Drugs, National Expert Committee on Monitoring Clinical Application of Antineoplastic Drugs, Breast Cancer Expert Committee of National Cancer Quality Control Center, Expert Committee on Chemotherapy Quality Control of Beijing Cancer Treatment Quality Control and Improvement Center   +5 more
wiley   +1 more source

Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC). [PDF]

Oncoimmunology
Sanborn RE, Jensen SM, Paustian C, Chang SC, Vetto E, Vu Q, Rajamanickam V, Bernard B, Koguchi Y, Redmond WL, Fox BA.   +10 more
europepmc   +1 more source

Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real‐Life National Setting Over a Decade

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Metastatic Ewing sarcoma (MES) has a poor prognosis. This multicenter observational study provides real‐world data on treatment patterns of patients with MES in France. Treatment characteristics, outcomes such as time to next treatment (TTNT) and overall survival (OS), and prognostic factors of patients aged ≥ 12 years treated for a MES in 11 ...
Coline Ducrot, Derek Dinart, Maeva Bonneau, Max Piffoux, Marie Sophie Minot, Juliane Mignot‐Posson, Thomas Grinda, Jordane Chaix, Sarah Winter, Pauline Gerard, Romain Duong, Berengère Narciso, Natacha Entze Werle, Cécile Vérité, Valérie Laurence, Axel Le Cesne, Pablo Berlanga, Camille Tlemsani, Pascaline Boudou‐Rouquette, Emmanuelle Bompas, Thibaud Valentin, Nadège Corradini, Mehdi Brahmi, Carine Bellera, Maud Toulmonde   +24 more
wiley   +1 more source

Chemotherapy-induced activation of caspase-1 and IL-1α release by cancer cells remotely skews myelopoiesis to drive pro tumorigenic systemic neutrophil-dominant inflammation. [PDF]

Nat Commun
Wong SQ, Hayashi K, Subel EJ, Huang YH, Gao H, Garcia HE, Porter SJ, Karabicici M, Hoi XP, Alonzo MD, Kasabyan A, Tsouko E, Shin CS, Bouchier-Hayes L, Korentzelos D, Chen C, Brooks M, Yin Z, Titus RS, Zhou L, Gong Y, Li Y, Wong ST, El-Zaatari Z, Kaushik D, Satkunasivam R, Nikolos F, Chan KS.   +27 more
europepmc   +1 more source

The Differential Impact of Neoadjuvant Therapies on the Tumor Microenvironment, Peripheral Biomarkers, and Survival in Pancreatic Cancer: A Retrospective Cohort Study. [PDF]

Cancers (Basel)
Silva T, Yamazaki T, Creasy JM, Gerry JM, Zheng-Lin B, Srivastava AJ, Young KH.   +6 more
europepmc   +1 more source

Malignant Ovarian Germ Cell Tumor—Survival and Reproductive Outcomes and Patterns of Relapse

Cancer Medicine, Volume 15, Issue 6, June 2026.
BLURB FOR ETOC: Patients presenting with advanced MOGCT can be offered fertility‐sparing surgery after neoadjuvant chemotherapy with no detriment in oncological outcome. ABSTRACT Background Malignant ovarian germ cell tumors [MOGCT] are rare cancers affecting young women and often present in advanced stages.
Sayak Dey, Srikant Anne, Sushmita Rath, Ravindra Nandhana, Seema Gulia, Biswajit Dash, Santosh Menon, Bharat Rekhi, Akshay Baheti, Nilesh Sable, Palak Popat, Sandeep Tandon, Kinjalka Ghosh, Lavanya Gurram, Sarika Shivram Parab, Apenla N. Logkumer, Sunita Jhadhav, Supriya Chopra, Shylasree T. Surappa, Vandana Bansal, Geeta Balsarkar, Kedar Deodhar, Amita Maheshwari, Jaya Ghosh, Sudeep Gupta   +24 more
wiley   +1 more source

Abnormal Sialylation Promotes Chemotherapy Resistance in Bladder Cancer via the PI3K-AKT-mTOR Signaling Pathway. [PDF]

Cancers (Basel)
Zhu J, Wang A, Tong H, Sun Y, Li T, Wu L, Zhang X, Qin Z, He W.   +8 more
europepmc   +1 more source

High‐Intensity Interval Training Boosts Immune Cells in Advanced Cancer Patients and Healthy Controls: Implications for Cancer Care

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Regular exercise improves quality of life (QoL) and reduces fatigue in advanced cancer patients (ACP), but acute immune responses are underexplored. This study investigated the effects of a single high‐intensity interval training (HIIT) session on natural killer (NK) cells and circulating innate lymphoid cells (cILCs) in ACP ...
Fabian Kiehl, Nico De Lazzari, Ronja Beller, Isabella Deppe, Sabrina B. Bennstein, Suzan Botzenhardt, Maria Rosa Salvador Comino, Mitra Tewes, Miriam Götte   +8 more
wiley   +1 more source